Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health Panel
Spoke,
SAN FRANCISCO, May 19, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the…
SAN FRANCISCO, May 19, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the…
- New 38-gene testing panel and clinical decision support tool analyzes a patient's genetics and co-medications for their…
- New 38-gene testing panel and clinical decision support tool analyzes a patient's genetics and co-medications for their…
- New 38-gene testing panel and clinical decision support tool analyzes a patient's genetics and co-medications for their…